These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38555139)

  • 21. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
    Carnero Contentti E; Okuda DT; Rojas JI; Chien C; Paul F; Alonso R
    J Neuroimaging; 2023; 33(5):688-702. PubMed ID: 37322542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement?
    Pawlitzki M; Ahring S; Rolfes L; Dziewas R; Warnecke T; Suntrup-Krueger S; Wiendl H; Klotz L; Meuth SG; Labeit B
    Eur J Neurol; 2021 May; 28(5):1765-1770. PubMed ID: 33338309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis.
    Chia NH; Redenbaugh V; Chen JJ; Pittock SJ; Flanagan EP
    Mult Scler; 2023 May; 29(6):748-752. PubMed ID: 36691800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
    Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
    JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology, Diagnosis, and Current Biomarkers in Neuromyelitis Optica Spectrum Disorders.
    Fiala C; Rotstein D; Pasic MD
    J Appl Lab Med; 2022 Jan; 7(1):305-310. PubMed ID: 34996075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
    Wei SH; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD).
    Diem L; Hammer H; Hoepner R; Pistor M; Remlinger J; Salmen A
    Int Rev Neurobiol; 2022; 164():129-178. PubMed ID: 36038203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromyelitis optica spectrum disorders.
    Paul S; Mondal GP; Bhattacharyya R; Ghosh KC; Bhat IA
    J Neurol Sci; 2021 Jan; 420():117225. PubMed ID: 33272591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.
    Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G
    Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
    Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
    Front Immunol; 2021; 12():647618. PubMed ID: 33796113
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
    Fujihara K; Cook LJ
    Curr Opin Neurol; 2020 Jun; 33(3):300-308. PubMed ID: 32374571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic neuritis in the era of biomarkers.
    Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
    Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder.
    Molazadeh N; Filippatou AG; Vasileiou ES; Levy M; Sotirchos ES
    J Neuroimmunol; 2021 Nov; 360():577702. PubMed ID: 34547512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease.
    Filippi M; Preziosa P; Margoni M; Rocca MA
    Neuroimaging Clin N Am; 2024 Aug; 34(3):293-316. PubMed ID: 38942518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
    Moheb N; Chen JJ
    Eye (Lond); 2023 Aug; 37(12):2391-2398. PubMed ID: 36928226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
    Ojha PT; Aglave VB; Soni G; Jagiasi KA; Singh RK; Singh RK; Nagendra S
    Neurol India; 2020; 68(5):1106-1114. PubMed ID: 33109860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.